Dysregulation in Plasma ω3 Fatty Acids Concentration and Serum Zinc in Heavy Alcohol-Drinking HCV Patients

Table 2

Liver injury, nutritional status, and serum nutrients in the study cohorts.

Groups/measures	HCV patients		AUD		Healthy volunteers (Gr. 5)
	HCV-only (Gr. 1)	HCV + AUD (Gr. 2)	AUD without liver injury (Gr. 3)	AUD with liver injury (Gr. 4)
Liver panel
ALT (U/L)	102.62 ± 54.85	121.68 ± 74.26	26.40 ± 8.44	84.48 ± 33.55	23.92 ± 8.65
AST (U/L)	88.85 ± 43.82	112.84 ± 64.41	25.02 ± 12.99	122.65 ± 80.30	33.67 ± 21.1
AST : ALT ratio	0.89 ± 0.24	1.03 ± 0.42	1.01 ± 0.48	1.44 ± 0.83	1.39 ± 0.53
Tbili (μmol/L)	0.68 ± 0.23	0.71 ± 0.39	0.69 ± 0.61	0.72 ± 0.61	0.73 ± 0.70
ALB (g/dL)	4.02 ± 0.36	3.83 ± 0.32	4.10 ± 0.32	4.10 ± 0.46	4.05 ± 0.32
Serum zinc and CONUT
Zn (mcg/dL)	70.23 ± 11.53	63.50 ± 17.40	79.20 ± 11.25	72.89 ± 26.80	72.10 ± 15.73
CONUT score	1.17 ± 0.94	1.78 ± 1.28	0.85 ± 1.13	1.23 ± 1.55	1.10 ± 1.31

ω3 and ω6 polyunsaturated fatty acids participating in inflammation in AUD and HCV + AUD patients. ALT: alanine transaminase; AST: aspartate transaminase; Tbili: Total bilirubin; ALB: albumin; Zn: serum zinc; CONUT: Controlling Nutritional Status.